Chinese scientists, using one of the world’s fastest supercomputers, Tianhe-2, have developed a promising therapeutic strategy to treat complications of diabetes. This was reported by the Xinhua news agency.
Supported by a high-throughput virtual screening platform (Virtual Screening on Tianhe-2), powered by Tianhe-2, a team of researchers from Guangdong Province (South China) discovered that branched-chain acylcarnitine 2MBC can significantly accelerate the formation of blood clots in the body. In addition, the researchers found that 2MBC has a direct effect on platelets, increasing their ability to aggregate, distribute and contract, which leads to accelerated blood clot formation.
According to a study published in the journal Cell Metabolism, this chemical is a metabolite of gut microflora, so pre-killing gut bacteria with antibiotics effectively stops its conversion process.
Diabetes is one of the most common chronic diseases worldwide. It can cause a range of complications, including blood clots, which are a leading cause of disability and death among people with diabetes.
